1st Detect Unveils Enhanced TRACER 1000 Narcotics Trace Detector Intended to Combat Synthetic Opiates and Novel Psychoactive Substances

Core Insights - Astrotech Corporation has launched the enhanced TRACER 1000™ Narcotics Trace Detector, which is designed to combat the global drug crisis by accurately screening for synthetic opiates and novel psychoactive substances [1][4]. Product Features - The TRACER 1000 NTD utilizes advanced mass spectrometry technology to detect minute traces of illicit substances, including fentanyl analogs and emerging synthetic drugs, which traditional methods struggle to identify [2][8]. - It offers full-spectrum screening capabilities, high precision and sensitivity, rapid analysis with results in seconds, and a user-friendly interface that minimizes training time for personnel [8]. Industry Context - The product addresses the growing crisis of synthetic opiates and novel psychoactive substances, which are contributing to overdose deaths and challenging public safety [3]. - The TRACER 1000 NTD is positioned as a critical tool for law enforcement, border security, first responders, and public health agencies to enhance safety and security [3][4]. Company Overview - 1st Detect, a subsidiary of Astrotech Corporation, specializes in developing, manufacturing, and selling trace detectors for security and detection markets [6]. - Astrotech Corporation is headquartered in Austin, Texas, and focuses on scalable companies based on innovative mass spectrometry technology [7].